FDA inspection
Rebiscan, Inc.: FDA inspection ending Oct 31, 2019
FDA inspection 1109151 · No Action Indicated (NAI) · Boston, MA
Key facts
| Inspection ID | 1109151 |
|---|---|
| Firm | Rebiscan, Inc. |
| FEI number | 3014522421 |
| Address | 100 Cambridge St Fl 14 |
| City | Boston |
| State | MA |
| ZIP | 02114 |
| Country | United States |
| Fiscal year | 2020 |
| Inspection end date | Oct 31, 2019 |
| Classification | No Action Indicated (NAI) |
| Project area | Compliance: Devices |
| Product type | Devices |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data